Independent Director · Atea Pharmaceuticals, Inc. (AVIR)

Bruno Lucidi director compensation at Atea Pharmaceuticals: $249K

Fiscal year 2025 director compensation for Bruno Lucidi at Atea Pharmaceuticals, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 27, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Bruno Lucidi’s full pay file as a PDF — free

More than this page: up to 10 years of Bruno’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Bruno Lucidi and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Atea Pharmaceuticals Director Compensation Table · all 3 fiscal years held
In US dollars, as Atea Pharmaceuticals reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$62,500$96,200$90,702$0$249,402
FY2022$57,500—$278,224—$335,724
FY2021$52,129—$539,912—$592,041

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Atea Pharmaceuticals, Inc. DEF 14A filed April 27, 2026, accession 0001193125-26-182293, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Atea Pharmaceuticals, Inc. filed document, accession 0001193125-26-182293. Every figure is read from that document and cited to the page and table it appears in. Filed April 27, 2026.

Get the Atea Pharmaceuticals Board Governance Report

$249,402 Bruno Lucidi, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 27, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Atea Pharmaceuticals pays directors a $45,000 cash retainer.

Committees

FY2025 · as the proxy prints them

Audit · Compensation

The rest of the Atea Pharmaceuticals board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Arthur KirschIndependent Director$415,333
Barbara DuncanIndependent Director$256,902
Bruce PolskyIndependent Director$249,402
Franklin BergerIndependent Director$282,902
Howard BermanIndependent Director$407,114
Jean-Pierre SommadossiChair of the Board—
Jerome AdamsIndependent Director$366,902
Polly MurphyIndependent Director$251,902

The full Atea Pharmaceuticals compensation record

free company brief

This page is one director within Atea Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the Atea Pharmaceuticals proxy · each links to its own free brief

Order AVIR

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report